Skip to main content
Top
Published in: Molecular Cancer 1/2013

Open Access 01-12-2013 | Reviewer acknowledgement

Thanking our peer reviewers

Author: Alan Storey

Published in: Molecular Cancer | Issue 1/2013

Login to get access

Contributing reviewers

As 2013 commences I would like to take a moment to reflect and recognize the peer reviewers that made the previous year possible. Listed below are those people who reviewed for Molecular Cancer last year. All are generous individuals who donated their time to assessing and improving our authors’ submissions. Your combined efforts have been invaluable to the editorial staff in maintaining the continued success of the journal in the Open Access forum.
The editors of Molecular Cancer would like to thank all the reviewers who contributed to the journal in Volume 11 (2012) by participating in the review process - taking time out of your busy schedules and even to volunteer - without your critical insights, hard work and support for the journal we wouldn’t be able to do what we do.
Metadata
Title
Thanking our peer reviewers
Author
Alan Storey
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Molecular Cancer / Issue 1/2013
Electronic ISSN: 1476-4598
DOI
https://doi.org/10.1186/1476-4598-12-10

Other articles of this Issue 1/2013

Molecular Cancer 1/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine